Home > Healthcare > Medical Devices > Surgical Devices > Ophthalmic Viscosurgical Devices Market

Ophthalmic Viscosurgical Devices Market Share

Report ID: GMI1134
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Major Ophthalmic Viscosurgical Devices Market Share

Some of the key players profiled in the ophthalmic viscosurgical devices market include:

Alcon
Amring Pharmaceuticals
Bohus Biotech AB
Bausch & Lomb Incorporated
Precision Lens
Carl Zeiss Meditec AG
Johnson & Johnson Surgical Vision, Inc.
CIMA Technology Inc.
Maxigen Biotech Inc.
Rayner Intraocular Lenses Ltd.

among others. These companies are engaging in strategic initiatives, mergers, and acquisitions to expand their business and launch new products to strengthen their procedure portfolio.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global ophthalmic viscosurgical devices market was over USD 732 million in 2022 and will witness 4% CAGR from 2023-2032 propelled by surging cases of cataract, glaucoma and age-related macular degeneration.

Demand for dispersive OVDs reached USD 242 million in 2022 as a result of multiple advantages, such as better endothelial protection, phacoemulsification, and ability to coat ocular structures.

Ophthalmic viscosurgical devices market size from cataract surgery application segment registered USD 249 million in 2022 owing to growing cataract operations and burgeoning public awareness.

North America ophthalmic viscosurgical devices market is slated to reach USD 257 million by the end of 2032 attributed to the availability of paper consultation services and stringent protocols for patient safety in the region.